Evorel Sequi

Evorel Sequi is a transdermal patch combining norethisterone acetate and estradiol hemihydrate. It is designed for hormone replacement therapy (HRT) to manage menopausal symptoms. This patch delivers hormones through the skin for systemic effects.

Evorel Sequi is primarily used for hormone replacement therapy (HRT) in women experiencing menopausal symptoms. The patch contains norethisterone acetate and estradiol hemihydrate, which work together to alleviate symptoms such as hot flashes, night sweats, and vaginal dryness. This transdermal patch is designed for continuous hormone delivery through the skin, providing a steady release of hormones into the bloodstream.

Common effects of Evorel Sequi may include skin irritation at the application site, breast tenderness, and headaches. Some users might experience changes in menstrual bleeding patterns or mood swings. These effects vary among individuals and typically subside as the body adjusts to the hormone therapy.

Evorel Sequi should be used under medical supervision. It is important to follow the prescribed application instructions and rotate the patch location to minimize skin irritation. Avoid applying the patch to broken or irritated skin. Regular monitoring is advised to assess the ongoing need for hormone replacement therapy.

Evorel Sequi may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to consult a healthcare provider before using this patch alongside other medications, especially those known to affect hormone levels or blood clotting. Alcohol consumption should be moderated, as it may influence the effectiveness of hormone therapy.